Disease/Infection News

RSS

New study to explore long-term impacts of COVID-19 on mental health

A new study will assess the long-term impacts of COVID-19 on the mental health of thousands of people – from the womb to old age.

13 May 2020

Researchers to test the strength and contact time of disinfectants used against viruses

Cleaning products, alcohol-based sanitizers and other common chemicals are all being used on surfaces to try to kill the virus that causes COVID-19, but knowing how much to use and how long to use it for is unknown, according to Craig Meyers, distinguished professor of microbiology and immunology and obstetrics and gynecology, College of Medicine, Penn State, who is looking at testing these chemicals to find out.

13 May 2020

New method to control inflammatory response induced by COVID-19

Severe COVID-19 illness can result in excessive inflammation throughout the body, including the lungs, heart and brain. University of Minnesota Twin Cities student Molly Gilligan recently published an article in the journal Cancer & Metastasis Reviews that studied the human body's robust inflammatory response to the SARS-CoV-2 virus, which is now recognized as a hallmark symptom.

13 May 2020

Passive immummization can offer instant, short-term fortification against infectious agents

The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority.

13 May 2020

Ortho’s COVID-19 total antibody test receives CE Mark

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its COVID-19 total antibody test received CE Mark.

From Ortho-Clinical Diagnostics, Inc. 13 May 2020

Researchers use “gene drive” technology to eliminate malaria mosquitoes in lab experiments

A modification that creates more male offspring was able to eliminate populations of malaria mosquitoes in lab experiments.

13 May 2020

The ‘new normal’ in post-COVID-19 dental practice

A new paper published in the British Dental Journal in May 2020 reports on the new ways of partnership between the dental industry and dental professionals, in view of the extremely high risk of aerosol production during dental procedures, to reduce the risk of passing on COVID-19 infection.

13 May 2020

Are pregnant women at higher risk from COVID-19? A Swedish study

A new study published by the Public Health Agency of Sweden in its Brief Report shows that compared to non-pregnant women, pregnant and postpartum women with COVID-19 have a higher risk of requiring intensive care.

12 May 2020

Johns Hopkins offers a free online course to become a contact tracer

Aside from mass testing, one of the most important methods to curb the transmission of the novel coronavirus is through extensive contact tracing. Now there's an opportunity to become a contact tracer as the Johns Hopkins Bloomberg School of Public Health has launched a six-hour online course.

12 May 2020

Organ transplantations plummet amid coronavirus pandemic

The coronavirus disease has spread rapidly across nearly all countries across the globe, with more than 4.25 million people infected. The pandemic has taken a toll on the lives of people, especially those in locked down nations. Aside from the negative impact on economic and social aspects, patients who are sick with other diseases may also suffer from the effects of the pandemic.

12 May 2020

Could JAK blockers help treat COVID-19?

A new study published in the journal Science Immunology in May 2020 reports that compounds that safely inhibit the JAK protein could be useful in treating COVID-19.

12 May 2020

A 'multi-omics' approach to the development of drugs against COVID-19

A new study published on the preprint server medRxiv* in May 2020 reports a multi-omics approach that could make it easier to develop drugs that are effective against COVID-19.

12 May 2020

UCF researchers win $200,000 to develop cough drops for controlling COVID-19 spread

A team of University of Central Florida researchers is looking at changing people's saliva to help manage the spread of COVID-19 as the nation gets ready to go back to work and school.

12 May 2020

Study provides further insights into the relationship between smoking and COVID-19

A Canadian study available on the preprint server medRxiv* shows that current smokers are slightly more likely than never smokers to test positive for coronavirus disease (COVID-19), but cautions about the possibility of reverse causality where smokers actually quit to avoid the disease.

12 May 2020

Using a smartphone to perform non-invasive at-home testing for COVID-19

In Pennsylvania and other U.S. states, one of the keys to safely reopening society amid the COVID-19 pandemic is providing sufficient testing so that new cases of the disease do not overwhelm the public healthcare system.

12 May 2020

COVID-19 has magnified health disparities among vulnerable population

The impact of COVID-19 on underserved and vulnerable populations, including persons of color, is addressed in a new roundtable discussion in Health Equity, a peer-reviewed open access journal.

12 May 2020

SARS-CoV-2 cell entry affinity varies across different host species

A new study from India, currently available on the preprint server bioRxiv*, estimated the probability and readiness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect cells of different animal species – and revealed many of them that could act as disease carriers.

12 May 2020

Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate

The Neurosciences Institute, mixed centre of the Spanish National Research Council and the Miguel Hernández University of Elche, have collaborated on the first clinical trial conducted in the world to test whether the defibrotide medicine, which has already been authorized to treat a severe obstruction of the hepatic sinusoidal veins of people who have undergone a bone marrow transplant, can be used as therapy against COVID-19.

12 May 2020

Neovii and Tel Aviv University partner to develop novel COVID-19 vaccine

Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.

12 May 2020

As deaths mount, coronavirus testing remains wildly inconsistent in long-term care

Mary Lanham's assisted living complex in Florida tested all residents for COVID-19 — once in March and again in April — even though no one showed symptoms.

12 May 2020